# Arkema Studies US Thiochemicals Expansion • CHEManager is the market-leading medium for the management of the chemical and pharmaceutical industry

> Arkema is studying a doubling of thiochemicals capacity at its Beaumont, Texas site to supply Novus International's proposed methionine hydroxy analogue plant. Arkema also plans to double methyl mercaptan output at Kerteh, Malaysia by 2020. A final investment decision is expected at the end of 2018, with the Texas plant due by summer 2021.

- Date: 2018-06-08 · published 2018-06-08T12:00:00.000Z
- Category: market · region US · magnitude low
- Page: https://feedsoft.ai/events/64869-arkema-studies-us-thiochemicals-expansion-chemanager-is-the-market-leading
- Commodities: [Methionine](https://feedsoft.ai/c/METH.md)

## Why it matters

Expanded methionine intermediate supply is a longer-term bearish factor for methionine prices, and it supports the case for rising methionine output tied to growing feed demand.

## Read by commodity

- METH: bearish ▼

## Sources

- chemanager-online.com: https://chemanager-online.com/en/news/arkema-studies-us-thiochemicals-expansion

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
